Akr1b10 | Rat | (4-oxo-3-\{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl\}-3,4-dihydrophthalazin-1-yl)acetic acid | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | zopolrestat inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and zopolrestat inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] | CTD | PMID:19028477 |
Akr1b10 | Rat | (4-oxo-3-\{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl\}-3,4-dihydrophthalazin-1-yl)acetic acid | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | zopolrestat results in decreased activity of AKR1B10 protein and zopolrestat results in decreased activity of AKR1B10 protein mutant form | CTD | PMID:18325492 |
Akr1b10 | Rat | (E)-cinnamyl alcohol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | (E,E)-2,4-hexadienal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 2 more ... | CTD | PMID:21329684 |
Akr1b10 | Rat | (R)-acetoin | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Acetoin | CTD | PMID:23295224 |
Akr1b10 | Rat | (R)-acetoin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2 more ... | CTD | PMID:23295224 |
Akr1b10 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of AKR1B10 mRNA | CTD | PMID:22206623 |
Akr1b10 | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | 13-dihydrodaunorubicin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of Daunorubicin] which results in increased chemical synthesis of daunorubicinol | CTD | PMID:19028477 |
Akr1b10 | Rat | 17beta-estradiol | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of AKR1B10 mRNA | CTD | PMID:25321415 |
Akr1b10 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of AKR1B10 mRNA | CTD | PMID:26496021 |
Akr1b10 | Rat | 17beta-estradiol | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of AKR1B10 mRNA and [Progesterone co-treated with Estradiol] results in decreased expression of AKR1B10 mRNA | CTD | PMID:17404688 and PMID:30165855 |
Akr1b10 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AKR1B10 mRNA | CTD | PMID:20106945 more ... |
Akr1b10 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AKR1B10 mRNA | CTD | PMID:33387578 |
Akr1b10 | Rat | 2-(chloromethyl)pyridine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-chloromethylpyridine results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1B10 mRNA | CTD | PMID:14656948 |
Akr1b10 | Rat | 2-acetamidofluorene | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-Acetylaminofluorene results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | 2-hexenal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 2-hexenal and AKR1B10 protein results in increased reduction of 2-hexenal metabolite | CTD | PMID:21329684 |
Akr1b10 | Rat | 2-hydroxypropanoic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of AKR1B10 mRNA | CTD | PMID:30851411 |
Akr1b10 | Rat | 2-palmitoylglycerol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of AKR1B10 mRNA | CTD | PMID:37199045 |
Akr1b10 | Rat | 2-tert-butylhydroquinone | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in increased expression of AKR1B10 mRNA | CTD | PMID:30806763 |
Akr1b10 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of AKR1B10 mRNA | CTD | PMID:28522335 |
Akr1b10 | Rat | 3-Hydroxybenzo[a]pyrene | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 3-hydroxybenzo(a)pyrene results in increased expression of AKR1B10 mRNA | CTD | PMID:26238291 |
Akr1b10 | Rat | 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-amino-3-methylimidazo(4 and 5-f)quinoline results in decreased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | 3-phenylprop-2-enal | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | cinnamaldehyde results in increased expression of AKR1B10 mRNA | CTD | PMID:30806763 |
Akr1b10 | Rat | 4,4'-methylene-bis-(2-chloroaniline) | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Methylenebis(chloroaniline) results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | bisphenol S results in increased expression of AKR1B10 mRNA | CTD | PMID:30951980 |
Akr1b10 | Rat | 4-hydroperoxycyclophosphamide | affects response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein affects the susceptibility to perfosfamide | CTD | PMID:18473730 |
Akr1b10 | Rat | 4-hydroxynon-2-enal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 4-hydroxy-2-nonenal | CTD | PMID:19013440 and PMID:21329684 |
Akr1b10 | Rat | 4-hydroxynon-2-enal | increases metabolic processing | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased metabolism of 4-hydroxy-2-nonenal | CTD | PMID:27417252 |
Akr1b10 | Rat | 4-hydroxynon-2-enal | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | Oleanolic Acid inhibits the reaction [AKR1B10 protein results in increased metabolism of 4-hydroxy-2-nonenal] | CTD | PMID:27417252 |
Akr1b10 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | Fenretinide results in increased expression of AKR1B10 mRNA | CTD | PMID:28973697 |
Akr1b10 | Rat | 4-methylpentanal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of isocaproaldehyde | CTD | PMID:19013440 |
Akr1b10 | Rat | 4-nitro-1,2-phenylenediamine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 1 and 2-diamino-4-nitrobenzene results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | 5-fluorouracil | affects expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Fluorouracil affects the expression of AKR1B10 mRNA | CTD | PMID:16584549 |
Akr1b10 | Rat | 7,12-dimethyltetraphene | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 9 more ... | CTD | PMID:26198647 |
Akr1b10 | Rat | 9,10-phenanthroquinone | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 9 and 10-phenanthrenequinone results in increased expression of AKR1B10 mRNA | CTD | PMID:24813866 |
Akr1b10 | Rat | 9,10-phenanthroquinone | increases metabolic processing | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased metabolism of 9 and 10-phenanthrenequinone | CTD | PMID:24813866 |
Akr1b10 | Rat | 9-cis-retinal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 9-cis-retinal | CTD | PMID:21851338 |
Akr1b10 | Rat | [6]-Shogaol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | shogaol metabolite results in increased expression of AKR1B10 protein more ... | CTD | PMID:25148906 |
Akr1b10 | Rat | acetoin | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Acetoin | CTD | PMID:23295224 |
Akr1b10 | Rat | acetoin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2 more ... | CTD | PMID:23295224 |
Akr1b10 | Rat | acrolein | affects metabolic processing | ISO | AKR1B10 (Homo sapiens) | 6480464 | Acrolein affects the metabolism of AKR1B10 protein and AKR1B10 protein affects the metabolism of Acrolein | CTD | PMID:17329238 and PMID:17597105 |
Akr1b10 | Rat | acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of AKR1B10 mRNA | CTD | PMID:38090360 |
Akr1b10 | Rat | acrolein | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Acrolein and AKR1B10 protein results in increased reduction of Acrolein metabolite | CTD | PMID:21329684 |
Akr1b10 | Rat | acrolein | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to Acrolein | CTD | PMID:17329238 and PMID:17597105 |
Akr1b10 | Rat | actinomycin D | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of AKR1B10 protein | CTD | PMID:38460933 |
Akr1b10 | Rat | adhumulone | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | adhumulone results in decreased activity of AKR1B10 protein | CTD | PMID:30469331 |
Akr1b10 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of AKR1B10 mRNA | CTD | PMID:23630614 and PMID:25378103 |
Akr1b10 | Rat | aflatoxin B1 | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of AKR1B10 mRNA | CTD | PMID:32234424 |
Akr1b10 | Rat | all-trans-4-oxoretinal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 4-oxoretinaldehyde | CTD | PMID:19014918 |
Akr1b10 | Rat | all-trans-dehydroretinal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of dehydroretinal | CTD | PMID:19014918 |
Akr1b10 | Rat | all-trans-retinal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Retinaldehyde | CTD | PMID:19014918 |
Akr1b10 | Rat | all-trans-retinal | increases metabolic processing | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased metabolism of Retinaldehyde | CTD | PMID:21329680 |
Akr1b10 | Rat | all-trans-retinol | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to Vitamin A and AKR1B10 protein results in decreased susceptibility to Vitamin A metabolite | CTD | PMID:19014918 |
Akr1b10 | Rat | Aloe emodin | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | aloe emodin results in decreased activity of AKR1B10 protein | CTD | PMID:35065925 |
Akr1b10 | Rat | alpha-hexylcinnamaldehyde | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | hexyl cinnamic aldehyde results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | amoxicillin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Amoxicillin results in increased expression of AKR1B10 mRNA | CTD | PMID:28444390 |
Akr1b10 | Rat | ampicillin | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Ampicillin results in decreased expression of AKR1B10 mRNA | CTD | PMID:21632981 and PMID:26198647 |
Akr1b10 | Rat | anthranilic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | anthranilic acid results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | antimonite | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA | CTD | PMID:32076005 |
Akr1b10 | Rat | arsane | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1B10 mRNA | CTD | PMID:32525701 |
Akr1b10 | Rat | arsane | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Arsenic results in increased expression of AKR1B10 mRNA | CTD | PMID:36861143 |
Akr1b10 | Rat | arsenic atom | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1B10 mRNA | CTD | PMID:32525701 |
Akr1b10 | Rat | arsenic atom | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Arsenic results in increased expression of AKR1B10 mRNA | CTD | PMID:36861143 |
Akr1b10 | Rat | arsenite(3-) | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of AKR1B10 mRNA | CTD | PMID:32076005 |
Akr1b10 | Rat | arsenous acid | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Akr1b10 | Rat | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of AKR1B10 mRNA | CTD | PMID:36841081 |
Akr1b10 | Rat | Augmentin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA | CTD | PMID:34767876 |
Akr1b10 | Rat | azathioprine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Azathioprine results in increased expression of AKR1B10 mRNA | CTD | PMID:22623647 and PMID:26198647 |
Akr1b10 | Rat | Bandrowski's base | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Bandrowski's base results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | benzalkonium chloride | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Benzalkonium Compounds results in increased expression of AKR1B10 mRNA | CTD | PMID:30806763 |
Akr1b10 | Rat | benzidine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | benzidine results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of AKR1B10 mRNA | CTD | PMID:21839799 |
Akr1b10 | Rat | benzo[a]pyrene | increases methylation | ISO | AKR1B10 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of AKR1B10 promoter | CTD | PMID:27901495 |
Akr1b10 | Rat | benzo[a]pyrene | affects methylation | ISO | AKR1B10 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of AKR1B10 exon | CTD | PMID:27901495 |
Akr1b10 | Rat | benzo[a]pyrene | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of AKR1B10 mRNA | CTD | PMID:19770486 |
Akr1b10 | Rat | benzo[a]pyrene | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of AKR1B10 mRNA and Benzo(a)pyrene results in increased expression of AKR1B10 protein | CTD | PMID:16545412 more ... |
Akr1b10 | Rat | Benzo[a]pyrene-7,8-diol | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7 and 8-dihydrodiol | CTD | PMID:21910479 |
Akr1b10 | Rat | benzo[a]pyrene-7,8-dione | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7 and 8-dione | CTD | PMID:21910479 |
Akr1b10 | Rat | benzoic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Benzoic Acid results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | beta-lapachone | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of AKR1B10 mRNA | CTD | PMID:38218311 |
Akr1b10 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Mustard Gas results in increased expression of AKR1B10 mRNA | CTD | PMID:25102026 |
Akr1b10 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of AKR1B10 mRNA | CTD | PMID:28412506 |
Akr1b10 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of AKR1B10 mRNA | CTD | PMID:26496021 |
Akr1b10 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of AKR1B10 mRNA | CTD | PMID:30816183 |
Akr1b10 | Rat | bisphenol A | affects expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | bisphenol A affects the expression of AKR1B10 mRNA | CTD | PMID:30903817 |
Akr1b10 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of AKR1B10 gene | CTD | PMID:28505145 |
Akr1b10 | Rat | bisphenol A | multiple interactions | ISO | Akr1b10 (Mus musculus) | 6480464 | [potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA and [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA] | CTD | PMID:27082013 |
Akr1b10 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of AKR1B10 mRNA | CTD | PMID:25181051 |
Akr1b10 | Rat | bortezomib | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Bortezomib results in increased expression of AKR1B10 mRNA and Bortezomib results in increased expression of AKR1B10 protein | CTD | PMID:21215737 |
Akr1b10 | Rat | butane-2,3-diol | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2 and 3-butylene glycol | CTD | PMID:23295224 |
Akr1b10 | Rat | butane-2,3-dione | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Diacetyl | CTD | PMID:23295224 |
Akr1b10 | Rat | butane-2,3-dione | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of Diacetyl] which results in increased chemical synthesis of Acetoin | CTD | PMID:23295224 |
Akr1b10 | Rat | cadmium atom | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Cadmium results in increased expression of AKR1B10 mRNA | CTD | PMID:21120746 and PMID:21172416 |
Akr1b10 | Rat | cadmium sulfate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1B10 mRNA | CTD | PMID:18654764 |
Akr1b10 | Rat | captan | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | Captan results in increased expression of AKR1B10 mRNA | CTD | PMID:31558096 |
Akr1b10 | Rat | carbamazepine | affects expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of AKR1B10 mRNA | CTD | PMID:25979313 |
Akr1b10 | Rat | carbon nanotube | decreases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 |
Akr1b10 | Rat | chlorambucil | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Chlorambucil results in decreased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | chromium(6+) | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of AKR1B10 mRNA | CTD | PMID:38479592 |
Akr1b10 | Rat | chrysin | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | chrysin results in decreased expression of AKR1B10 mRNA and chrysin results in decreased expression of AKR1B10 protein | CTD | PMID:23994249 |
Akr1b10 | Rat | cinnamyl alcohol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | ciprofibrate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | ciprofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and ciprofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] | CTD | PMID:19028477 |
Akr1b10 | Rat | ciprofibrate | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | ciprofibrate results in decreased activity of AKR1B10 protein and ciprofibrate results in decreased activity of AKR1B10 protein mutant form | CTD | PMID:18325492 |
Akr1b10 | Rat | cisplatin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of AKR1B10 mRNA | CTD | PMID:19561079 and PMID:27392435 |
Akr1b10 | Rat | cisplatin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of AKR1B10 mRNA | CTD | PMID:27392435 |
Akr1b10 | Rat | cisplatin | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to Cisplatin | CTD | PMID:27417252 |
Akr1b10 | Rat | clavulanic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Clavulanic Acid results in increased expression of AKR1B10 mRNA | CTD | PMID:34767876 |
Akr1b10 | Rat | Clofop | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | fenofibric acid inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and fenofibric acid inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] | CTD | PMID:19028477 |
Akr1b10 | Rat | Clofop | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | fenofibric acid results in decreased activity of AKR1B10 protein and fenofibric acid results in decreased activity of AKR1B10 protein mutant form | CTD | PMID:18325492 |
Akr1b10 | Rat | cobalt dichloride | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1B10 mRNA | CTD | PMID:18654764 |
Akr1b10 | Rat | Cohumulone | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | cohumulone results in decreased activity of AKR1B10 protein | CTD | PMID:30469331 |
Akr1b10 | Rat | copper atom | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1B10 mRNA | CTD | PMID:20971185 |
Akr1b10 | Rat | copper(0) | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1B10 mRNA | CTD | PMID:20971185 |
Akr1b10 | Rat | copper(II) chloride | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of AKR1B10 mRNA | CTD | PMID:38568856 |
Akr1b10 | Rat | copper(II) sulfate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of AKR1B10 mRNA | CTD | PMID:19549813 |
Akr1b10 | Rat | crotonaldehyde | affects metabolic processing | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-butenal affects the metabolism of AKR1B10 protein | CTD | PMID:17597105 |
Akr1b10 | Rat | crotonaldehyde | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to 2-butenal | CTD | PMID:17597105 |
Akr1b10 | Rat | crotonaldehyde | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 2-butenal and AKR1B10 protein results in increased reduction of 2-butenal metabolite | CTD | PMID:21329684 |
Akr1b10 | Rat | cyclosporin A | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of AKR1B10 mRNA | CTD | PMID:25562108 |
Akr1b10 | Rat | cyclosporin A | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of AKR1B10 mRNA | CTD | PMID:27989131 |
Akr1b10 | Rat | D-glyceraldehyde | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... | CTD | PMID:17329238 and PMID:19028477 |
Akr1b10 | Rat | D-glyceraldehyde | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | Glyceraldehyde results in decreased activity of AKR1B10 protein | CTD | PMID:30469331 |
Akr1b10 | Rat | D-glyceraldehyde | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Glyceraldehyde | CTD | PMID:19014918 and PMID:19028477 |
Akr1b10 | Rat | D-glyceraldehyde | increases metabolic processing | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased metabolism of Glyceraldehyde | CTD | PMID:18325492 |
Akr1b10 | Rat | daunorubicin | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to Daunorubicin | CTD | PMID:19028477 |
Akr1b10 | Rat | daunorubicin | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Daunorubicin | CTD | PMID:19028477 |
Akr1b10 | Rat | daunorubicin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of Daunorubicin] which results in increased chemical synthesis of daunorubicinol more ... | CTD | PMID:19028477 |
Akr1b10 | Rat | DDT | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | DDT results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | diarsenic trioxide | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Akr1b10 | Rat | dibenzo[a,l]pyrene | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | dibenzo(a and l)pyrene results in decreased expression of AKR1B10 mRNA | CTD | PMID:31255691 |
Akr1b10 | Rat | diethyl maleate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | diethyl maleate results in increased expression of AKR1B10 mRNA | CTD | PMID:33545341 |
Akr1b10 | Rat | diethylstilbestrol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Antimony Potassium Tartrate results in increased expression of AKR1B10 mRNA | CTD | PMID:28713220 |
Akr1b10 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA | CTD | PMID:32076005 |
Akr1b10 | Rat | diquat | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Diquat results in increased expression of AKR1B10 mRNA | CTD | PMID:21172416 |
Akr1b10 | Rat | disulfiram | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Disulfiram results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | dorsomorphin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1B10 mRNA | CTD | PMID:27188386 |
Akr1b10 | Rat | doxorubicin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in decreased susceptibility to Doxorubicin] which results in increased expression of MMP2 mRNA more ... | CTD | PMID:25686905 |
Akr1b10 | Rat | doxorubicin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of AKR1B10 mRNA | CTD | PMID:29803840 |
Akr1b10 | Rat | doxorubicin | decreases response to substance | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:25686905 |
Akr1b10 | Rat | emodin | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | Emodin results in decreased activity of AKR1B10 protein | CTD | PMID:35065925 |
Akr1b10 | Rat | ethanol | affects expression | ISO | Akr1b10 (Mus musculus) | 6480464 | Ethanol affects the expression of AKR1B10 mRNA | CTD | PMID:30319688 |
Akr1b10 | Rat | ethoxyquin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Ethoxyquin results in increased expression of AKR1B10 mRNA | CTD | PMID:21277289 |
Akr1b10 | Rat | ethoxyquin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [Ethoxyquin results in increased expression of AKR1B10 mRNA] | CTD | PMID:21277289 |
Akr1b10 | Rat | Ethyl 1-benzyl-3-hydroxy- 2-oxo[5H]pyrrole-4-carboxylate | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate results in decreased activity of AKR1B10 protein | CTD | PMID:18325492 |
Akr1b10 | Rat | Ethyl 1-benzyl-3-hydroxy- 2-oxo[5H]pyrrole-4-carboxylate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] | CTD | PMID:19028477 |
Akr1b10 | Rat | Ethyl acrylate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | ethyl acrylate results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | eugenol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Eugenol results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 more ... |
Akr1b10 | Rat | farnesal | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of farnesal | CTD | PMID:21187079 |
Akr1b10 | Rat | farnesol | increases chemical synthesis | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased chemical synthesis of Farnesol | CTD | PMID:21187079 |
Akr1b10 | Rat | fenofibrate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | Fenofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and Fenofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] | CTD | PMID:19028477 |
Akr1b10 | Rat | fenofibrate | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | Fenofibrate results in decreased activity of AKR1B10 protein and Fenofibrate results in decreased activity of AKR1B10 protein mutant form | CTD | PMID:18325492 |
Akr1b10 | Rat | Fidarestat | affects binding | ISO | AKR1B10 (Homo sapiens) | 6480464 | NADP binds to AKR1B10 protein mutant form binds to fidarestat | CTD | PMID:23295227 |
Akr1b10 | Rat | Fidarestat | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | fidarestat binds to and results in decreased activity of AKR1B10 protein mutant form | CTD | PMID:23295227 |
Akr1b10 | Rat | flucloxacillin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Floxacillin results in increased expression of AKR1B10 mRNA | CTD | PMID:28444390 |
Akr1b10 | Rat | folpet | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | folpet results in increased expression of AKR1B10 mRNA | CTD | PMID:31558096 |
Akr1b10 | Rat | formaldehyde | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of AKR1B10 mRNA | CTD | PMID:27664576 |
Akr1b10 | Rat | formononetin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | formononetin results in increased expression of AKR1B10 mRNA | CTD | PMID:37793997 |
Akr1b10 | Rat | Frangulin A | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | frangulin A results in decreased activity of AKR1B10 protein | CTD | PMID:35065925 |
Akr1b10 | Rat | Frangulin B | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | frangulin B results in decreased activity of AKR1B10 protein | CTD | PMID:35065925 |
Akr1b10 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of AKR1B10 mRNA | CTD | PMID:25539665 |
Akr1b10 | Rat | gemfibrozil | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | Gemfibrozil results in decreased activity of AKR1B10 protein mutant form | CTD | PMID:18325492 |
Akr1b10 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of AKR1B10 mRNA | CTD | PMID:33387578 |
Akr1b10 | Rat | geranylgeraniol | increases chemical synthesis | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased chemical synthesis of geranylgeraniol | CTD | PMID:21187079 |
Akr1b10 | Rat | glyceraldehyde | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... | CTD | PMID:17329238 and PMID:19028477 |
Akr1b10 | Rat | glyceraldehyde | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | Glyceraldehyde results in decreased activity of AKR1B10 protein | CTD | PMID:30469331 |
Akr1b10 | Rat | glyceraldehyde | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of Glyceraldehyde | CTD | PMID:19014918 and PMID:19028477 |
Akr1b10 | Rat | glyceraldehyde | increases metabolic processing | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased metabolism of Glyceraldehyde | CTD | PMID:18325492 |
Akr1b10 | Rat | gold atom | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Gold results in increased expression of AKR1B10 mRNA | CTD | PMID:29705079 |
Akr1b10 | Rat | gold(0) | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Gold results in increased expression of AKR1B10 mRNA | CTD | PMID:29705079 |
Akr1b10 | Rat | hexane | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | n-hexane results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | hexane-2,3-dione | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of 2 and 3-hexanedione] which results in increased chemical synthesis of Hexanones | CTD | PMID:23295224 |
Akr1b10 | Rat | hexane-2,3-dione | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 2 and 3-hexanedione | CTD | PMID:23295224 |
Akr1b10 | Rat | hydrogen peroxide | affects expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of AKR1B10 mRNA | CTD | PMID:23410634 |
Akr1b10 | Rat | hydroquinone | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of AKR1B10 mRNA | CTD | PMID:31256213 |
Akr1b10 | Rat | indan-1-ol | increases oxidation | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased oxidation of 1-indanol | CTD | PMID:19013440 |
Akr1b10 | Rat | indometacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of AKR1B10 mRNA | CTD | PMID:36868495 |
Akr1b10 | Rat | isoeugenol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | isoeugenol results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | isoniazide | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Isoniazid results in increased expression of AKR1B10 mRNA | CTD | PMID:28444390 |
Akr1b10 | Rat | Isoxanthohumol | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | isoxanthohumol results in decreased activity of AKR1B10 protein | CTD | PMID:35065925 |
Akr1b10 | Rat | L-ascorbic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Ascorbic Acid results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | lead diacetate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | lead acetate results in increased expression of AKR1B10 mRNA | CTD | PMID:38568856 |
Akr1b10 | Rat | lead(II) chloride | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1B10 mRNA | CTD | PMID:18654764 |
Akr1b10 | Rat | lead(II) chloride | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | lead chloride results in increased expression of AKR1B10 mRNA | CTD | PMID:18654764 |
Akr1b10 | Rat | Licochalcone B | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of AKR1B10 mRNA | CTD | PMID:33647349 |
Akr1b10 | Rat | lipopolysaccharide | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of AKR1B10 mRNA | CTD | PMID:35811015 |
Akr1b10 | Rat | lipopolysaccharide | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 |
Akr1b10 | Rat | LY294002 | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of AKR1B10 protein | CTD | PMID:23994249 |
Akr1b10 | Rat | menadione | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Vitamin K 3 results in increased expression of AKR1B10 mRNA | CTD | PMID:23410634 and PMID:34767876 |
Akr1b10 | Rat | methyl salicylate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | methyl salicylate results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | methylisothiazolinone | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of AKR1B10 mRNA | CTD | PMID:30806763 |
Akr1b10 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of AKR1B10 mRNA | CTD | PMID:21215737 |
Akr1b10 | Rat | N-methyl-N-nitrosourea | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | Methylnitrosourea results in increased expression of AKR1B10 mRNA | CTD | PMID:25270620 |
Akr1b10 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1B10 mRNA | CTD | PMID:14656948 |
Akr1b10 | Rat | N-Nitrosopyrrolidine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in increased expression of AKR1B10 mRNA | CTD | PMID:32234424 |
Akr1b10 | Rat | NADP zwitterion | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... | CTD | PMID:17329238 and PMID:21910479 |
Akr1b10 | Rat | NADP zwitterion | increases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | NADP results in increased activity of AKR1B10 protein | CTD | PMID:23295224 |
Akr1b10 | Rat | NADP zwitterion | affects binding | ISO | AKR1B10 (Homo sapiens) | 6480464 | NADP binds to AKR1B10 protein mutant form binds to fidarestat | CTD | PMID:23295227 |
Akr1b10 | Rat | NADP zwitterion | decreases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased reduction of NADP | CTD | PMID:19013440 |
Akr1b10 | Rat | NADP(+) | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... | CTD | PMID:17329238 and PMID:21910479 |
Akr1b10 | Rat | NADP(+) | increases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | NADP results in increased activity of AKR1B10 protein | CTD | PMID:23295224 |
Akr1b10 | Rat | NADP(+) | affects binding | ISO | AKR1B10 (Homo sapiens) | 6480464 | NADP binds to AKR1B10 protein mutant form binds to fidarestat | CTD | PMID:23295227 |
Akr1b10 | Rat | NADP(+) | decreases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in decreased reduction of NADP | CTD | PMID:19013440 |
Akr1b10 | Rat | naphthalenes | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of and affects the activity of Naphthalenes | CTD | PMID:21910479 |
Akr1b10 | Rat | nickel atom | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Nickel results in increased expression of AKR1B10 mRNA | CTD | PMID:25583101 |
Akr1b10 | Rat | nickel sulfate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | nitrososulfamethoxazole | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 4-nitrososulfamethoxazole results in increased expression of AKR1B10 mRNA | CTD | PMID:28444390 |
Akr1b10 | Rat | Nutlin-3 | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of AKR1B10 protein | CTD | PMID:38460933 |
Akr1b10 | Rat | O-methyleugenol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of AKR1B10 mRNA | CTD | PMID:32234424 |
Akr1b10 | Rat | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of AKR1B10 mRNA | CTD | PMID:18417182 |
Akr1b10 | Rat | ochratoxin A | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of AKR1B10 mRNA | CTD | PMID:32905824 |
Akr1b10 | Rat | oleanolic acid | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | Oleanolic Acid inhibits the reaction [[AKR1B10 protein results in decreased susceptibility to Doxorubicin] which results in increased expression of MMP2 mRNA] more ... | CTD | PMID:25686905 and PMID:27417252 |
Akr1b10 | Rat | p-chloromercuribenzenesulfonic acid | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | 4-Chloromercuribenzenesulfonate results in decreased activity of AKR1B10 protein | CTD | PMID:23261715 |
Akr1b10 | Rat | para-Cresidine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | cresidine results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | paracetamol | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of AKR1B10 mRNA | CTD | PMID:21420995 and PMID:29067470 |
Akr1b10 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of AKR1B10 mRNA | CTD | PMID:33387578 |
Akr1b10 | Rat | paraquat | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Paraquat results in increased expression of AKR1B10 mRNA | CTD | PMID:35182771 |
Akr1b10 | Rat | pazopanib | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | pazopanib inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] | CTD | PMID:29356861 |
Akr1b10 | Rat | pentane-2,3-dione | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [AKR1B10 protein results in increased reduction of 2 and 3-pentanedione] which results in increased chemical synthesis of Pentanones | CTD | PMID:23295224 |
Akr1b10 | Rat | pentane-2,3-dione | increases reduction | ISO | AKR1B10 (Homo sapiens) | 6480464 | AKR1B10 protein results in increased reduction of 2 and 3-pentanedione | CTD | PMID:23295224 |
Akr1b10 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of AKR1B10 mRNA | CTD | PMID:37995155 |
Akr1b10 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of AKR1B10 mRNA | CTD | PMID:27153767 |
Akr1b10 | Rat | perfluorooctanoic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of AKR1B10 mRNA and perfluorooctanoic acid results in increased expression of AKR1B10 protein | CTD | PMID:26879310 and PMID:27153767 |
Akr1b10 | Rat | phenethyl caffeate | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | caffeic acid phenethyl ester results in decreased activity of AKR1B10 protein | CTD | PMID:27163852 |
Akr1b10 | Rat | phenobarbital | affects expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of AKR1B10 mRNA | CTD | PMID:19084549 |
Akr1b10 | Rat | phenobarbital | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Phenobarbital results in increased expression of AKR1B10 protein | CTD | PMID:35881160 |
Akr1b10 | Rat | phenol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Phenol results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | phenylmercury acetate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of AKR1B10 mRNA | CTD | PMID:26272509 |
Akr1b10 | Rat | phenylmercury acetate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1B10 mRNA | CTD | PMID:27188386 |
Akr1b10 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Tetradecanoylphorbol Acetate results in increased expression of JUN mRNA] which results in decreased expression of AKR1B10 mRNA and U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of AKR1B10 mRNA] | CTD | PMID:25463304 |
Akr1b10 | Rat | phorbol 13-acetate 12-myristate | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of AKR1B10 mRNA and Tetradecanoylphorbol Acetate results in decreased expression of AKR1B10 protein | CTD | PMID:25463304 and PMID:26198647 |
Akr1b10 | Rat | picoxystrobin | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of AKR1B10 mRNA | CTD | PMID:33512557 |
Akr1b10 | Rat | pimecrolimus | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | pimecrolimus inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] | CTD | PMID:29356861 |
Akr1b10 | Rat | pirinixic acid | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AKR1B10 mRNA more ... | CTD | PMID:19028477 and PMID:19710929 |
Akr1b10 | Rat | pirinixic acid | multiple interactions | ISO | Akr1b10 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AKR1B10 mRNA | CTD | PMID:19710929 |
Akr1b10 | Rat | pirinixic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | pirinixic acid results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | pirinixic acid | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | pirinixic acid results in decreased activity of AKR1B10 protein and pirinixic acid results in decreased activity of AKR1B10 protein mutant form | CTD | PMID:18325492 |
Akr1b10 | Rat | potassium bromate | multiple interactions | ISO | Akr1b10 (Mus musculus) | 6480464 | [potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA more ... | CTD | PMID:27082013 |
Akr1b10 | Rat | potassium bromate | affects expression | ISO | Akr1b10 (Mus musculus) | 6480464 | potassium bromate affects the expression of AKR1B10 mRNA | CTD | PMID:27082013 |
Akr1b10 | Rat | progesterone | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of AKR1B10 mRNA | CTD | PMID:17404688 |
Akr1b10 | Rat | progesterone | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Progesterone results in decreased expression of AKR1B10 mRNA | CTD | PMID:17404688 |
Akr1b10 | Rat | propan-2-ol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | 2-Propanol results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | propiconazole | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [propiconazole co-treated with tebuconazole] results in increased expression of AKR1B10 mRNA | CTD | PMID:30989312 |
Akr1b10 | Rat | propiconazole | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | propiconazole results in increased expression of AKR1B10 mRNA | CTD | PMID:30989312 |
Akr1b10 | Rat | quercetin | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of AKR1B10 mRNA | CTD | PMID:21632981 |
Akr1b10 | Rat | quercetin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Quercetin results in increased expression of AKR1B10 mRNA | CTD | PMID:34767876 |
Akr1b10 | Rat | quinolin-8-ol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Oxyquinoline results in increased expression of AKR1B10 mRNA | CTD | PMID:21632981 and PMID:26198647 |
Akr1b10 | Rat | rac-lactic acid | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | rac-lactic acid | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of AKR1B10 mRNA | CTD | PMID:30851411 |
Akr1b10 | Rat | reserpine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Reserpine results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | resorcinol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | resorcinol results in increased expression of AKR1B10 mRNA | CTD | PMID:22623647 more ... |
Akr1b10 | Rat | resveratrol | multiple interactions | ISO | Akr1b10 (Mus musculus) | 6480464 | [resveratrol co-treated with HMGB1 protein] results in increased expression of AKR1B10 mRNA | CTD | PMID:25979658 |
Akr1b10 | Rat | rifampicin | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Rifampin results in increased expression of AKR1B10 mRNA | CTD | PMID:29356861 |
Akr1b10 | Rat | rifampicin | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | pazopanib inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] and pimecrolimus inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] | CTD | PMID:29356861 |
Akr1b10 | Rat | rotenone | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of AKR1B10 mRNA | CTD | PMID:33512557 |
Akr1b10 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 |
Akr1b10 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of AKR1B10 mRNA | CTD | PMID:35811015 |
Akr1b10 | Rat | SB 431542 | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1B10 mRNA | CTD | PMID:27188386 |
Akr1b10 | Rat | silicon dioxide | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of AKR1B10 mRNA | CTD | PMID:25895662 |
Akr1b10 | Rat | silicon dioxide | decreases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of AKR1B10 mRNA | CTD | PMID:19073995 |
Akr1b10 | Rat | silicon dioxide | increases secretion | ISO | AKR1B10 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased secretion of AKR1B10 protein | CTD | PMID:25895662 |
Akr1b10 | Rat | silver atom | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Silver results in increased expression of AKR1B10 mRNA | CTD | PMID:26014281 |
Akr1b10 | Rat | silver(0) | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Silver results in increased expression of AKR1B10 mRNA | CTD | PMID:26014281 |
Akr1b10 | Rat | sodium arsenate | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1B10 mRNA | CTD | PMID:32525701 |
Akr1b10 | Rat | sodium arsenite | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of AKR1B10 mRNA | CTD | PMID:23876855 more ... |
Akr1b10 | Rat | sodium arsenite | decreases expression | ISO | Akr1b10 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of AKR1B10 mRNA | CTD | PMID:37682722 |
Akr1b10 | Rat | sodium arsenite | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of AKR1B10 mRNA | CTD | PMID:32076005 |
Akr1b10 | Rat | sodium dodecyl sulfate | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 and PMID:30806763 |
Akr1b10 | Rat | sorbinil | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | sorbinil inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and sorbinil inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] | CTD | PMID:19028477 |
Akr1b10 | Rat | sorbinil | decreases activity | ISO | AKR1B10 (Homo sapiens) | 6480464 | sorbinil results in decreased activity of AKR1B10 protein | CTD | PMID:18325492 |
Akr1b10 | Rat | sulforaphane | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of AKR1B10 mRNA | CTD | PMID:24383545 more ... |
Akr1b10 | Rat | sulindac | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | Sulindac analog binds to and results in decreased activity of AKR1B10 protein and Sulindac binds to and results in decreased activity of AKR1B10 protein | CTD | PMID:25532697 |
Akr1b10 | Rat | sulindac sulfone | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | sulindac sulfone binds to and results in decreased activity of AKR1B10 protein | CTD | PMID:25532697 |
Akr1b10 | Rat | tebuconazole | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | tebuconazole results in increased expression of AKR1B10 mRNA | CTD | PMID:30989312 |
Akr1b10 | Rat | tebuconazole | multiple interactions | ISO | AKR1B10 (Homo sapiens) | 6480464 | [propiconazole co-treated with tebuconazole] results in increased expression of AKR1B10 mRNA | CTD | PMID:30989312 |
Akr1b10 | Rat | temozolomide | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of AKR1B10 mRNA | CTD | PMID:31758290 |
Akr1b10 | Rat | tert-butyl hydroperoxide | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of AKR1B10 mRNA | CTD | PMID:23410634 and PMID:34767876 |
Akr1b10 | Rat | tetraphene | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | benz(a)anthracene results in increased expression of AKR1B10 mRNA | CTD | PMID:22236718 |
Akr1b10 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of AKR1B10 mRNA | CTD | PMID:23411599 and PMID:34492290 |
Akr1b10 | Rat | titanium dioxide | decreases phosphorylation | ISO | AKR1B10 (Homo sapiens) | 6480464 | titanium dioxide results in decreased phosphorylation of AKR1B10 protein | CTD | PMID:21439344 |
Akr1b10 | Rat | trans-isoeugenol | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | isoeugenol results in increased expression of AKR1B10 mRNA | CTD | PMID:20566472 |
Akr1b10 | Rat | Tributyltin oxide | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of AKR1B10 mRNA | CTD | PMID:26198647 |
Akr1b10 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of AKR1B10 mRNA | CTD | PMID:33387578 |
Akr1b10 | Rat | Triptolide | decreases expression | EXP | | 6480464 | triptolide results in decreased expression of AKR1B10 protein | CTD | PMID:32519852 |
Akr1b10 | Rat | troglitazone | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | troglitazone results in increased expression of AKR1B10 mRNA | CTD | PMID:25572481 |
Akr1b10 | Rat | urethane | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Urethane results in decreased expression of AKR1B10 mRNA | CTD | PMID:28818685 |
Akr1b10 | Rat | valproic acid | decreases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of AKR1B10 mRNA | CTD | PMID:29154799 |
Akr1b10 | Rat | valproic acid | affects expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of AKR1B10 mRNA | CTD | PMID:25979313 |
Akr1b10 | Rat | vitamin E | increases expression | ISO | AKR1B10 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of AKR1B10 mRNA | CTD | PMID:34767876 |